Phase I trials with ET-743, a marine derived (MD) anticancer agent

• 30 September 1999
• journal article
• abstracts
• Published by Elsevier in European Journal Of Cancer
• Vol. 35, S283-283
• https://doi.org/10.1016/s0959-8049(99)81555-x

Abstract

Keywords

• PHASE I TRIALS
• ANTICANCER AGENT
• MARINE DERIVED